INS and myeloid sarcoma: The MS group had a significantly higher BMI, BMI-SDS, systolic and diastolic BP, waist circumference (Tables 3),  triglyceride levels, HOMA-IR, FGIR and fasting insulin levels than the non-MS group (p<0.001), whereas HDL cholesterol and Apo-A levels of children with MS were lower than those of  non-MS group.